Protective effect of saffron (its active constituent, crocin) on oxidative stress and hepatic injury in streptozotocin induced diabetic rats

Gene Therapy and Molecular Biology

Volumn 16, Issue 1, 2014, Pages 160-171

  Altinoz, Eyup ^a   Oner, Zulal ^b   Elbe, Hulya ^b   Turkoz, Yusuf ^b   Cigremis, Yilmaz ^b  

^a KARABUK UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Blood glucose; Crocin; Diabetes mellitus; Liver; Oxidative stress; Saffron

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CROCIN; CROCUS SATIVUS EXTRACT; GLUCOSE; GLUTATHIONE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; XANTHINE OXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CELL VACUOLE; CONTROLLED STUDY; CROCUS SATIVUS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; LIVER CELL; LIVER CONGESTION; LIVER INJURY; LIVER PARENCHYMA; LIVER PROTECTION; LIVER SINUSOID; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT OUTCOME;

RATTUS;

EID: 84920692177     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Abdullaev F.I. (1993) Biological effects of saffron. Biofactors. 4, 83-86. Abdullaev F.I. (2002) Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med. 227, 20-25.
2. Abdullaev F.I. (2002) Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med. 227, 20-25
3. Ana Angelica H.F., Ethel L.B., Ary F.J., Cristiano M.G. (2009) Effect of Naringerin on Biochemical parameters in the streptozotocininduced diabetic rats. Brazilian Archives of Biology and Technology. 52, 51-59.
4. Arkkila P.E., Koskinen P.J., Kantola I.M., Viikari J.S. (2001) Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes. Diabetes Research and Clinical Practice. 52, 113-118.
5. Asdaq S.M., Inamdar M.N. (2010) Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Appl. Biochem. Biotechnol. 162, 358-372.
6. Assimopoulou A.N., Sinakos Z., Papageorgiou V.P. (2005) Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother. Res. 19, 997-1000.
7. Bathaie S.Z., Mousavi Z. (2010) New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr. 50, 761-86.
8. Berlett B.S., Stadtman E.R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272, 20313-20316.
9. Bradford M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72, 248-54.
10. Coldiron A.D., Sanders R.A. Watkins J.B. (2002) Effects of Combined Quercetin and Coenzyme Q10 Treatment on Oxidative Stress in Normal and Diabetic Rats. J. Biochem. Molecular Toxicology. 16(4),197-202.
11. Desco M.C., Asensi M., Marquez R., Martinez-Valls J., Vento M., Pallardo F.V., Sastre J., Vina J. (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes. 51, 1118-24.
12. Elgazar A.F., Rezq A.A., Bukhari H.A. (2013) Antihiperlipidemik Effect of saffron Extract in Alloxan Induced Diabetic Rats. European Journal of Biological Sciences 5(1):14-22.
13. Ellman G.L. (1959) Tissue sulphydryl groups. Arch. Biochem. Biophys. 82, 70-77.
14. Feillet-Coudray C., Rock E., Coudray C., Grzelkowska K., Azais-Braesco V., Dardevet D., Mazur A. (1999) Lipid peroxidation and antioxidant status in experimental diabetes. Clinica Chimica Acta. 284(1), 31-43.
15. Fridovich I. (1995). Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64, 97-112.
16. Ghoneim A.I., Abdel-Naim A.B., Khalifa A.E., El-Denshary E.S. (2002) Protective effect of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res. 46, 273-279.
17. Giaccio M. (2004). Crocetin from saffron: An active component of an ancient spice. Crit. Rev. Food Sci. Nutr. 44, 155-172.
18. Giaccio M. (2004). Crocetin from saffron: An active component of an ancient spice. Crit. Rev. Food Sci. Nutr. 44, 155-172.
19. Guneli E., Tugyan K., Ozturk H., Gumustekin M., Cilaker S., Uysal N. (2008) Effect of Melatonin on Testicular Damage in Streptozotocin-Induced Diabetes Rats. Eur. Surg. Res. 78, 479-484.
20. Halliwell B. (1992). Free radicals, antioxidants and human disease where are we now. J. Lab. Clin. Med. 119, 598.
21. Halliwell B., Gutteridge J.M.C. (2002) Free radicals in biology and medicine, Oxford, UK: Clarendon. 27.
22. Hamden K., Carreau S., Jamoussi K., Miladi S., Lajmi S., Aloulou D., Ayadi F., Elfeki A. (2009) 1a 25 Dihydroxyvitamin D3: Therapeutic and prevantive effects against oxidative stress, Hepatic, Pancreatic and Renal Injury in Alloxan-Induced Diabetes in Rats. J. Nurt. Sci. Vitaminol. 55, 215-222.
23. Hile R., Nishino T. (1995) Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 9, 995-1003.
24. Hosseinpour Chermahini S., Fadzilah Adibah A.M., Mohamad Roji S., Taghizadeh E., Salehnezhad S. (2010) Impact of saffron as an anti-cancer and anti-tumor herb. Afr. J. Pharm. Pharmacol. 4(11), 834-840.
25. Hosseinzadeh H., Sadeghnia H.R., Ziaee T., Danaee A. (2005) Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusioninduced oxidative damage in rats. J. Pharm. Pharm. Sci. 8, 387-93.
26. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. (1998). Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin. Scie. 94(6), 623-632.
27. Liakopoulou-Kyriakides M., Kyriakidis D.A. (2002). Crocus sativus biological active constituents. Studies Nat. Prod. Chem. 26, 293-312.
28. Lipscombe L., Hux J. (2007) Trend in diabetes prevalence, incidence and mortality in Ontario, Canada (1995-2005): Apopulation-based study. Lancet. 369, 750-756.
29. Maritim A.C., Sanders R.A., Watkins J.B. (2003) Effect of alpha lipoic acid on biomarkers of oxidatif stres in streptozotoc in-induced diabetic rats. J. Nutr. Biochem. 14, 288-294.
30. Marjani A. (2010) Lipid peroxidation alteration in type 2 diabetic patients. Pak. J. Biol. Sci. 13, 723-730.
31. Marnett L.J. (2000) Oxyradicals and DNA damage. Carcinogenesis, 21: 361-370.
32. Matsumoto S., Koshiishi I., Inoguchi T., Nawata H., Utsumi H. (2003). Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic. Res. 37, 767-72.
33. Medina J., Moreno-Otero R. (2005) Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs. 65, 2445-2461.
34. Mohajeri D., Amouoghli Tabrizi B., Mousavi G.H., Mesgari M. (2008) Anti-diabetic activity of Crocus sativus L. (saffron) stigma ethanolic extract in alloxan-induced diabetic rats. Res. J. Biol. Sci. 3(9), 1102-1108.
35. Mohajeri D., Mousavi G.H., Doustar Y. (2009) Antihyperglycemic and pancreas-protective effects of Crocus sativus L. (Saffron) stigma ethanolic extract on rats with alloxan-Induced diabetes. J Biol Sci; 9(4): 302-310.
36. Mohammed R., Daryoush M., Ali R., Yousef D., Mehrdad N. (2012) Protective effect of saffron (Dried stigmas of Crocus sativus L.) on hepatic tissue injury in streptozotocin-induced diabetic rats. Journal of animal and Veterinary advances. 11(12), 1985-1994.
37. Mohammed R., Daryoush M., Ali R., Yousef D., Mehrdad N. (2011) Attenuation of oxidative stress of hepatic tissue by ethanolic extract of saffron (dried stigmas of Crocus sativus L.) in streptozotocin (STZ)-induced diabetic rats. African Journal of Pharmacy and Pharmacology. 5(19), 2166-2173.
38. Momtaz S., Abdollahi M. (2012) A comprehensive review of biochemical and moleculer evidences from animal and human studies on the role of oxidative stress in aging: An Epiphenomenon or the Cause. Asian J. Anim. Vet. Adv. 7, 1-19.
39. Mousavi SH, Tayarani NZ and Parsaee H. (2010) Protective effect of saffron extract and crocin on Reactive oxygenspecies- Mediated High Glucose-Induced Toxicity in PC12 Cells. Cell Mol. Neurobiol. 30,185-191
40. Nacítarhan S., Özben T., Tuncer N. (1995) Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radical Biol. Med. 19, 893-896.
41. Noguchi N. (2002). Novel insights into the molecular mechanisms of the antiatherosclerotic properties of antioxidants the alternatives to radical scavenging. Free Radical Biol. Med. 33, 1480-1489.
42. Nourooz-Zadeh J., Rahimi A., Tajaddini-Sarmadi J., Tritschler H., Rosen P., Halliwel B., Betteridge D.J. (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 40, 647-653.
43. Obrosova I.G., Fathallah L., Liu E., Nourooz-Zadeh J. (2003) Early Oxidative Stress In The Diabetic Kidney: Effect Of DL-alfa-Lipoic Acid. Free Radical Biology&Medicine. 34, 186-195.
44. Ohkawa H., Ohishi N., Yagi K. (1979) Assay of lipid peroxides in animal tissue by thiobarbutiric acid reaction. Anal. Biochem. 95, 351-358.
45. Prajda N., Weber G. (1975) Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett. 59(2),245-249.
46. Rajaei Z et al (2013) Antihyperglycemic and Antioxidant Activity of Crocin in Streptozotocin- Induced Diabetic Rats. Journal of Medicinal Food. 16(3),206-210.
47. Ramash B., Viswanathan P., Pugalendi K.V. (2007) Protective effect of umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 566, 231-239.
48. Reitman S., Frankel S. (1957) A colorimetrik methot for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am. J. Clin. Pathol. 28: 56-63.
49. Saxena A.K., Srivastava P., Kale R.K., Baquer N.Z. (1993) Impaired antioxidant status in diabetic rat liver. Biochem. Pharmacol. 45(3): 539-542.
50. Schmidt M., Betti G., Hensel A. (2007) Saffron in phytotherapy: pharmacology and clinical uses. Wien Med. Wochenschr. 157, 315-9.
51. Szkudelski T. (2001) The Mechanism of Alloxan and Streptozotocin Action in Cells of the Rat Pancreas. Physiol. Res. 50, 536-546.
52. Taniyama Y., Griendling K.K. (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 42, 1075-1081.
53. Wilcox C.S., Gutterman D. (2005). Focus on oxidative stress in the cardiovascular and renal systems. Am. J. Physiol, Heart Circ. Physiol. 288, 3-6.
54. Winterhalter P., Straubinger M. (2000) Saffronrenewed interest in an ancient spice. Food Rev. Int. 16(1), 39-59.
55. Wohaieb S.A., Godin D.V. (1987) Alterationin free radical tissue defense mechanisms in streptozotocin diabetes in rats: Effect of insulin treatment. Diabetes. 36, 1014-1018.
56. Zhang X.F., Tan B.K. (2000) Antihyperglycaemic and antioxidant properties of Andrographis particulate in normal and diabetic rats. Clin. Exp. Pharmacol. Physiol. 27,358-363.
57. Zheng Y.Q., Liu J.X., Wang J.N., Xu L. (2007) Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Research. 1138, 86-94.